You are here

Article Text

Article menu
Download PDFPDF
DTB Select
New restrictions and precautions for the use of fluoroquinolones

https://doi.org/10.1136/dtb.2019.000050

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Review of: Medicines and Healthcare products Regulatory Agency. Fluoroquinolone antibiotics: new restrictions and precautions for use due to very rare reports of disabling and potentially long-lasting or irreversible side effects. Drug Safety Update 2019;12:1.

    Key points

    • Very rare but serious adverse events affecting the musculoskeletal and nervous systems have been observed in people taking systemic fluoroquinolones.

    • The most common events were tendonitis, tendon rupture and paraesthesia.

    • At the first sign of tendonitis, treatment with fluoroquinolones should be stopped.

    • Use fluoroquinolones with special caution in people aged over 60 years, people with renal impairment and those who have had solid organ transplants.

    Very rare but serious and potentially irreversible adverse effects including tendinopathy and paraesthesia …

    View Full Text

    Footnotes

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; Internally peer reviewed.